context
stringlengths 21
24.6k
| category
stringclasses 2
values | entity
stringlengths 1
12
| entity_type
stringclasses 5
values | query
stringlengths 97
3.31k
| answer
stringlengths 12
168
|
|---|---|---|---|---|---|
The Back River royalties have been accounted for as an asset acquisition and the $ 51 million cash consideration, plus direct transaction costs, have been allocated to development ($ 42 million) and exploration ($ 9 million) stage royalty interests within
|
text
|
51
|
monetaryItemType
|
text: <entity> 51 </entity> <entity type> monetaryItemType </entity type> <context> The Back River royalties have been accounted for as an asset acquisition and the $ 51 million cash consideration, plus direct transaction costs, have been allocated to development ($ 42 million) and exploration ($ 9 million) stage royalty interests within </context>
|
us-gaap:AssetAcquisitionConsiderationTransferred
|
The Back River royalties have been accounted for as an asset acquisition and the $ 51 million cash consideration, plus direct transaction costs, have been allocated to development ($ 42 million) and exploration ($ 9 million) stage royalty interests within
|
text
|
42
|
monetaryItemType
|
text: <entity> 42 </entity> <entity type> monetaryItemType </entity type> <context> The Back River royalties have been accounted for as an asset acquisition and the $ 51 million cash consideration, plus direct transaction costs, have been allocated to development ($ 42 million) and exploration ($ 9 million) stage royalty interests within </context>
|
us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost
|
The Back River royalties have been accounted for as an asset acquisition and the $ 51 million cash consideration, plus direct transaction costs, have been allocated to development ($ 42 million) and exploration ($ 9 million) stage royalty interests within
|
text
|
9
|
monetaryItemType
|
text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> The Back River royalties have been accounted for as an asset acquisition and the $ 51 million cash consideration, plus direct transaction costs, have been allocated to development ($ 42 million) and exploration ($ 9 million) stage royalty interests within </context>
|
us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost
|
Debt issuance costs of $ 3.1 million are included within Other assets on our consolidated balance sheets.
|
text
|
3.1
|
monetaryItemType
|
text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> Debt issuance costs of $ 3.1 million are included within Other assets on our consolidated balance sheets. </context>
|
us-gaap:UnamortizedDebtIssuanceExpense
|
During the year ended December 31, 2024, we repaid the remaining $ 250 million of outstanding borrowings on our revolving credit facility, making the entire $ 1 billion revolving credit facility available as of December 31, 2024.
|
text
|
250
|
monetaryItemType
|
text: <entity> 250 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, we repaid the remaining $ 250 million of outstanding borrowings on our revolving credit facility, making the entire $ 1 billion revolving credit facility available as of December 31, 2024. </context>
|
us-gaap:RepaymentsOfLongTermDebt
|
During the year ended December 31, 2024, we repaid the remaining $ 250 million of outstanding borrowings on our revolving credit facility, making the entire $ 1 billion revolving credit facility available as of December 31, 2024.
|
text
|
1
|
monetaryItemType
|
text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, we repaid the remaining $ 250 million of outstanding borrowings on our revolving credit facility, making the entire $ 1 billion revolving credit facility available as of December 31, 2024. </context>
|
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
|
Interest expense recognized on the revolving credit facility for the years ended December 31, 2024, 2023, and 2022 was approximately $ 6.3 million, $ 28.4 million, and $ 10.0 million, respectively, and included interest on the outstanding borrowings and the amortization of the debt issuance costs. We were in compliance with each financial covenant (leverage ratio and interest coverage ratio) under the revolving credit facility as of December 31, 2024.
|
text
|
6.3
|
monetaryItemType
|
text: <entity> 6.3 </entity> <entity type> monetaryItemType </entity type> <context> Interest expense recognized on the revolving credit facility for the years ended December 31, 2024, 2023, and 2022 was approximately $ 6.3 million, $ 28.4 million, and $ 10.0 million, respectively, and included interest on the outstanding borrowings and the amortization of the debt issuance costs. We were in compliance with each financial covenant (leverage ratio and interest coverage ratio) under the revolving credit facility as of December 31, 2024. </context>
|
us-gaap:InterestExpenseDebt
|
Interest expense recognized on the revolving credit facility for the years ended December 31, 2024, 2023, and 2022 was approximately $ 6.3 million, $ 28.4 million, and $ 10.0 million, respectively, and included interest on the outstanding borrowings and the amortization of the debt issuance costs. We were in compliance with each financial covenant (leverage ratio and interest coverage ratio) under the revolving credit facility as of December 31, 2024.
|
text
|
28.4
|
monetaryItemType
|
text: <entity> 28.4 </entity> <entity type> monetaryItemType </entity type> <context> Interest expense recognized on the revolving credit facility for the years ended December 31, 2024, 2023, and 2022 was approximately $ 6.3 million, $ 28.4 million, and $ 10.0 million, respectively, and included interest on the outstanding borrowings and the amortization of the debt issuance costs. We were in compliance with each financial covenant (leverage ratio and interest coverage ratio) under the revolving credit facility as of December 31, 2024. </context>
|
us-gaap:InterestExpenseDebt
|
Interest expense recognized on the revolving credit facility for the years ended December 31, 2024, 2023, and 2022 was approximately $ 6.3 million, $ 28.4 million, and $ 10.0 million, respectively, and included interest on the outstanding borrowings and the amortization of the debt issuance costs. We were in compliance with each financial covenant (leverage ratio and interest coverage ratio) under the revolving credit facility as of December 31, 2024.
|
text
|
10.0
|
monetaryItemType
|
text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> Interest expense recognized on the revolving credit facility for the years ended December 31, 2024, 2023, and 2022 was approximately $ 6.3 million, $ 28.4 million, and $ 10.0 million, respectively, and included interest on the outstanding borrowings and the amortization of the debt issuance costs. We were in compliance with each financial covenant (leverage ratio and interest coverage ratio) under the revolving credit facility as of December 31, 2024. </context>
|
us-gaap:InterestExpenseDebt
|
On February 13, 2024, RGLD Gold AG, a subsidiary of the Company, entered into a Processing Cost Support Agreement (the "Mount Milligan Cost Support Agreement") with Centerra Gold Inc. ("Centerra") with respect to the Mount Milligan Mine ("Mount Milligan") for cash consideration of $ 24.5 million, 50,000 ounces ("Deferred Gold Consideration") of gold to be delivered in the future and a free cash flow interest. The cost support allowed for the extension of the mine from 2032 to 2035 and the potential to extend the mine life beyond 2035.
|
text
|
24.5
|
monetaryItemType
|
text: <entity> 24.5 </entity> <entity type> monetaryItemType </entity type> <context> On February 13, 2024, RGLD Gold AG, a subsidiary of the Company, entered into a Processing Cost Support Agreement (the "Mount Milligan Cost Support Agreement") with Centerra Gold Inc. ("Centerra") with respect to the Mount Milligan Mine ("Mount Milligan") for cash consideration of $ 24.5 million, 50,000 ounces ("Deferred Gold Consideration") of gold to be delivered in the future and a free cash flow interest. The cost support allowed for the extension of the mine from 2032 to 2035 and the potential to extend the mine life beyond 2035. </context>
|
us-gaap:ContractWithCustomerLiabilityNoncurrent
|
We have identified two material revenue sources in our business: stream interests and royalty interests. These identified revenue sources are consistent with our reportable segments as discussed in Note
|
text
|
two
|
integerItemType
|
text: <entity> two </entity> <entity type> integerItemType </entity type> <context> We have identified two material revenue sources in our business: stream interests and royalty interests. These identified revenue sources are consistent with our reportable segments as discussed in Note </context>
|
us-gaap:NumberOfReportableSegments
|
In November 2015, our stockholders approved the 2015 Omnibus Long-Term Incentive Plan (“2015 LTIP”). Under the 2015 LTIP, 2,500,000 shares of common stock have been authorized for future grants to officers, directors, key employees and other persons. The 2015 LTIP provides for the grant of stock options, unrestricted stock, restricted stock, dividend
|
text
|
2500000
|
sharesItemType
|
text: <entity> 2500000 </entity> <entity type> sharesItemType </entity type> <context> In November 2015, our stockholders approved the 2015 Omnibus Long-Term Incentive Plan (“2015 LTIP”). Under the 2015 LTIP, 2,500,000 shares of common stock have been authorized for future grants to officers, directors, key employees and other persons. The 2015 LTIP provides for the grant of stock options, unrestricted stock, restricted stock, dividend </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
The total intrinsic value of options exercised during the years ended December 31, 2024, and 2023, and 2022 was $ 0.2 million, $ 0.5 million and $ 0.2 million, respectively.
|
text
|
0.2
|
monetaryItemType
|
text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised during the years ended December 31, 2024, and 2023, and 2022 was $ 0.2 million, $ 0.5 million and $ 0.2 million, respectively. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
The total intrinsic value of options exercised during the years ended December 31, 2024, and 2023, and 2022 was $ 0.2 million, $ 0.5 million and $ 0.2 million, respectively.
|
text
|
0.5
|
monetaryItemType
|
text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised during the years ended December 31, 2024, and 2023, and 2022 was $ 0.2 million, $ 0.5 million and $ 0.2 million, respectively. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
As of December 31, 2024, there was no unrecognized stock-based compensation expense related to unvested stock options.
|
text
|
no
|
monetaryItemType
|
text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was no unrecognized stock-based compensation expense related to unvested stock options. </context>
|
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
The total intrinsic value of SSARs exercised during the years ended December 31, 2024, 2023 and 2022 was $ 1.4 million, $ 0.7 million and $ 0.2 million, respectively.
|
text
|
1.4
|
monetaryItemType
|
text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of SSARs exercised during the years ended December 31, 2024, 2023 and 2022 was $ 1.4 million, $ 0.7 million and $ 0.2 million, respectively. </context>
|
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
|
The total intrinsic value of SSARs exercised during the years ended December 31, 2024, 2023 and 2022 was $ 1.4 million, $ 0.7 million and $ 0.2 million, respectively.
|
text
|
0.7
|
monetaryItemType
|
text: <entity> 0.7 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of SSARs exercised during the years ended December 31, 2024, 2023 and 2022 was $ 1.4 million, $ 0.7 million and $ 0.2 million, respectively. </context>
|
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
|
The total intrinsic value of SSARs exercised during the years ended December 31, 2024, 2023 and 2022 was $ 1.4 million, $ 0.7 million and $ 0.2 million, respectively.
|
text
|
0.2
|
monetaryItemType
|
text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of SSARs exercised during the years ended December 31, 2024, 2023 and 2022 was $ 1.4 million, $ 0.7 million and $ 0.2 million, respectively. </context>
|
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
|
As of December 31, 2024, there was no unrecognized stock-based compensation expense related to unvested SSARs.
|
text
|
no
|
monetaryItemType
|
text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was no unrecognized stock-based compensation expense related to unvested SSARs. </context>
|
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
As of December 31, 2024, total unrecognized stock-based compensation expense related to Performance Shares was approximately $ 5.2 million, which is expected to be recognized over the average remaining vesting period of 1.7 years.
|
text
|
5.2
|
monetaryItemType
|
text: <entity> 5.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, total unrecognized stock-based compensation expense related to Performance Shares was approximately $ 5.2 million, which is expected to be recognized over the average remaining vesting period of 1.7 years. </context>
|
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
Officers, non-executive directors and certain employees may be granted shares of restricted stock that vest on continued service alone (“Restricted Stock”). During the year ended December 31, 2024, officers and certain employees were granted 57,330 shares of Restricted Stock. Restricted Stock granted to officers and certain employees during the years ended December 31, 2024, 2023 and 2022, vest ratably over three years from the date of grant. Also, our non-executive directors were granted 8,520 shares of Restricted Stock during the year ended December 31, 2024. The non-executive directors’ shares of Restricted Stock vest 50 % immediately and 50 % one year after the date of grant.
|
text
|
57330
|
sharesItemType
|
text: <entity> 57330 </entity> <entity type> sharesItemType </entity type> <context> Officers, non-executive directors and certain employees may be granted shares of restricted stock that vest on continued service alone (“Restricted Stock”). During the year ended December 31, 2024, officers and certain employees were granted 57,330 shares of Restricted Stock. Restricted Stock granted to officers and certain employees during the years ended December 31, 2024, 2023 and 2022, vest ratably over three years from the date of grant. Also, our non-executive directors were granted 8,520 shares of Restricted Stock during the year ended December 31, 2024. The non-executive directors’ shares of Restricted Stock vest 50 % immediately and 50 % one year after the date of grant. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
Officers, non-executive directors and certain employees may be granted shares of restricted stock that vest on continued service alone (“Restricted Stock”). During the year ended December 31, 2024, officers and certain employees were granted 57,330 shares of Restricted Stock. Restricted Stock granted to officers and certain employees during the years ended December 31, 2024, 2023 and 2022, vest ratably over three years from the date of grant. Also, our non-executive directors were granted 8,520 shares of Restricted Stock during the year ended December 31, 2024. The non-executive directors’ shares of Restricted Stock vest 50 % immediately and 50 % one year after the date of grant.
|
text
|
8520
|
sharesItemType
|
text: <entity> 8520 </entity> <entity type> sharesItemType </entity type> <context> Officers, non-executive directors and certain employees may be granted shares of restricted stock that vest on continued service alone (“Restricted Stock”). During the year ended December 31, 2024, officers and certain employees were granted 57,330 shares of Restricted Stock. Restricted Stock granted to officers and certain employees during the years ended December 31, 2024, 2023 and 2022, vest ratably over three years from the date of grant. Also, our non-executive directors were granted 8,520 shares of Restricted Stock during the year ended December 31, 2024. The non-executive directors’ shares of Restricted Stock vest 50 % immediately and 50 % one year after the date of grant. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
Officers, non-executive directors and certain employees may be granted shares of restricted stock that vest on continued service alone (“Restricted Stock”). During the year ended December 31, 2024, officers and certain employees were granted 57,330 shares of Restricted Stock. Restricted Stock granted to officers and certain employees during the years ended December 31, 2024, 2023 and 2022, vest ratably over three years from the date of grant. Also, our non-executive directors were granted 8,520 shares of Restricted Stock during the year ended December 31, 2024. The non-executive directors’ shares of Restricted Stock vest 50 % immediately and 50 % one year after the date of grant.
|
text
|
50
|
percentItemType
|
text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> Officers, non-executive directors and certain employees may be granted shares of restricted stock that vest on continued service alone (“Restricted Stock”). During the year ended December 31, 2024, officers and certain employees were granted 57,330 shares of Restricted Stock. Restricted Stock granted to officers and certain employees during the years ended December 31, 2024, 2023 and 2022, vest ratably over three years from the date of grant. Also, our non-executive directors were granted 8,520 shares of Restricted Stock during the year ended December 31, 2024. The non-executive directors’ shares of Restricted Stock vest 50 % immediately and 50 % one year after the date of grant. </context>
|
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
|
As of December 31, 2024, total unrecognized stock-based compensation expense related to Restricted Stock was approximately $ 6.6 million, which is expected to be recognized over the weighted-average vesting period of 1.7 years.
|
text
|
6.6
|
monetaryItemType
|
text: <entity> 6.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, total unrecognized stock-based compensation expense related to Restricted Stock was approximately $ 6.6 million, which is expected to be recognized over the weighted-average vesting period of 1.7 years. </context>
|
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
The effective tax rate for the year ended December 31, 2024, was 22 % which included a $ 13.0 million U.S. GILTI income tax expense related to the consideration from the Mount Milligan Cost Support Agreement. The effective tax rates for the years ended December 31, 2023 and 2022, were 14.9 % and 12.1 %, respectively, which included income tax benefits attributable to the release of a valuation allowance on certain foreign deferred tax assets.
|
text
|
22
|
percentItemType
|
text: <entity> 22 </entity> <entity type> percentItemType </entity type> <context> The effective tax rate for the year ended December 31, 2024, was 22 % which included a $ 13.0 million U.S. GILTI income tax expense related to the consideration from the Mount Milligan Cost Support Agreement. The effective tax rates for the years ended December 31, 2023 and 2022, were 14.9 % and 12.1 %, respectively, which included income tax benefits attributable to the release of a valuation allowance on certain foreign deferred tax assets. </context>
|
us-gaap:EffectiveIncomeTaxRateContinuingOperations
|
The effective tax rate for the year ended December 31, 2024, was 22 % which included a $ 13.0 million U.S. GILTI income tax expense related to the consideration from the Mount Milligan Cost Support Agreement. The effective tax rates for the years ended December 31, 2023 and 2022, were 14.9 % and 12.1 %, respectively, which included income tax benefits attributable to the release of a valuation allowance on certain foreign deferred tax assets.
|
text
|
13.0
|
monetaryItemType
|
text: <entity> 13.0 </entity> <entity type> monetaryItemType </entity type> <context> The effective tax rate for the year ended December 31, 2024, was 22 % which included a $ 13.0 million U.S. GILTI income tax expense related to the consideration from the Mount Milligan Cost Support Agreement. The effective tax rates for the years ended December 31, 2023 and 2022, were 14.9 % and 12.1 %, respectively, which included income tax benefits attributable to the release of a valuation allowance on certain foreign deferred tax assets. </context>
|
us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount
|
The effective tax rate for the year ended December 31, 2024, was 22 % which included a $ 13.0 million U.S. GILTI income tax expense related to the consideration from the Mount Milligan Cost Support Agreement. The effective tax rates for the years ended December 31, 2023 and 2022, were 14.9 % and 12.1 %, respectively, which included income tax benefits attributable to the release of a valuation allowance on certain foreign deferred tax assets.
|
text
|
14.9
|
percentItemType
|
text: <entity> 14.9 </entity> <entity type> percentItemType </entity type> <context> The effective tax rate for the year ended December 31, 2024, was 22 % which included a $ 13.0 million U.S. GILTI income tax expense related to the consideration from the Mount Milligan Cost Support Agreement. The effective tax rates for the years ended December 31, 2023 and 2022, were 14.9 % and 12.1 %, respectively, which included income tax benefits attributable to the release of a valuation allowance on certain foreign deferred tax assets. </context>
|
us-gaap:EffectiveIncomeTaxRateContinuingOperations
|
The effective tax rate for the year ended December 31, 2024, was 22 % which included a $ 13.0 million U.S. GILTI income tax expense related to the consideration from the Mount Milligan Cost Support Agreement. The effective tax rates for the years ended December 31, 2023 and 2022, were 14.9 % and 12.1 %, respectively, which included income tax benefits attributable to the release of a valuation allowance on certain foreign deferred tax assets.
|
text
|
12.1
|
percentItemType
|
text: <entity> 12.1 </entity> <entity type> percentItemType </entity type> <context> The effective tax rate for the year ended December 31, 2024, was 22 % which included a $ 13.0 million U.S. GILTI income tax expense related to the consideration from the Mount Milligan Cost Support Agreement. The effective tax rates for the years ended December 31, 2023 and 2022, were 14.9 % and 12.1 %, respectively, which included income tax benefits attributable to the release of a valuation allowance on certain foreign deferred tax assets. </context>
|
us-gaap:EffectiveIncomeTaxRateContinuingOperations
|
We review the measurement of our deferred tax assets at each balance sheet date. Considering all available positive and negative evidence, including but not limited to recent earnings history and forecasted future results, the Company believes it is more likely-than-not that all net deferred tax assets not currently burdened with a valuation allowance will be fully realized. As of December 31, 2024 and 2023, we recorded a valuation allowance of $ 44.7 million and $ 40.8 million, respectively. The valuation allowance remaining at December 31, 2024 is attributable to US foreign tax credits of
|
text
|
44.7
|
monetaryItemType
|
text: <entity> 44.7 </entity> <entity type> monetaryItemType </entity type> <context> We review the measurement of our deferred tax assets at each balance sheet date. Considering all available positive and negative evidence, including but not limited to recent earnings history and forecasted future results, the Company believes it is more likely-than-not that all net deferred tax assets not currently burdened with a valuation allowance will be fully realized. As of December 31, 2024 and 2023, we recorded a valuation allowance of $ 44.7 million and $ 40.8 million, respectively. The valuation allowance remaining at December 31, 2024 is attributable to US foreign tax credits of </context>
|
us-gaap:DeferredTaxAssetsValuationAllowance
|
We review the measurement of our deferred tax assets at each balance sheet date. Considering all available positive and negative evidence, including but not limited to recent earnings history and forecasted future results, the Company believes it is more likely-than-not that all net deferred tax assets not currently burdened with a valuation allowance will be fully realized. As of December 31, 2024 and 2023, we recorded a valuation allowance of $ 44.7 million and $ 40.8 million, respectively. The valuation allowance remaining at December 31, 2024 is attributable to US foreign tax credits of
|
text
|
40.8
|
monetaryItemType
|
text: <entity> 40.8 </entity> <entity type> monetaryItemType </entity type> <context> We review the measurement of our deferred tax assets at each balance sheet date. Considering all available positive and negative evidence, including but not limited to recent earnings history and forecasted future results, the Company believes it is more likely-than-not that all net deferred tax assets not currently burdened with a valuation allowance will be fully realized. As of December 31, 2024 and 2023, we recorded a valuation allowance of $ 44.7 million and $ 40.8 million, respectively. The valuation allowance remaining at December 31, 2024 is attributable to US foreign tax credits of </context>
|
us-gaap:DeferredTaxAssetsValuationAllowance
|
$ 39.7 million and capital losses of $ 1.9 million, net operating losses of $ 2.2 million, and other tax attribute carryforwards of $ 0.9 million in non-US subsidiaries.
|
text
|
39.7
|
monetaryItemType
|
text: <entity> 39.7 </entity> <entity type> monetaryItemType </entity type> <context> $ 39.7 million and capital losses of $ 1.9 million, net operating losses of $ 2.2 million, and other tax attribute carryforwards of $ 0.9 million in non-US subsidiaries. </context>
|
us-gaap:DeferredTaxAssetsValuationAllowance
|
$ 39.7 million and capital losses of $ 1.9 million, net operating losses of $ 2.2 million, and other tax attribute carryforwards of $ 0.9 million in non-US subsidiaries.
|
text
|
1.9
|
monetaryItemType
|
text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> $ 39.7 million and capital losses of $ 1.9 million, net operating losses of $ 2.2 million, and other tax attribute carryforwards of $ 0.9 million in non-US subsidiaries. </context>
|
us-gaap:DeferredTaxAssetsValuationAllowance
|
$ 39.7 million and capital losses of $ 1.9 million, net operating losses of $ 2.2 million, and other tax attribute carryforwards of $ 0.9 million in non-US subsidiaries.
|
text
|
2.2
|
monetaryItemType
|
text: <entity> 2.2 </entity> <entity type> monetaryItemType </entity type> <context> $ 39.7 million and capital losses of $ 1.9 million, net operating losses of $ 2.2 million, and other tax attribute carryforwards of $ 0.9 million in non-US subsidiaries. </context>
|
us-gaap:DeferredTaxAssetsValuationAllowance
|
$ 39.7 million and capital losses of $ 1.9 million, net operating losses of $ 2.2 million, and other tax attribute carryforwards of $ 0.9 million in non-US subsidiaries.
|
text
|
0.9
|
monetaryItemType
|
text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> $ 39.7 million and capital losses of $ 1.9 million, net operating losses of $ 2.2 million, and other tax attribute carryforwards of $ 0.9 million in non-US subsidiaries. </context>
|
us-gaap:DeferredTaxAssetsValuationAllowance
|
As of December 31, 2024 and 2023, we had $ 5.9 million and $ 4.7 million of net operating loss carryforwards offset by a valuation allowance of $ 2.2 million and $ 1.7 million, respectively. The majority of the tax loss carryforwards are in jurisdictions that allow a twenty-year carry-forward period. These losses do not begin to expire until the 2038 tax year, and the Company anticipates utilizing $ 3.7 million of the net operating loss carryforwards as of December 31, 2024.
|
text
|
5.9
|
monetaryItemType
|
text: <entity> 5.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, we had $ 5.9 million and $ 4.7 million of net operating loss carryforwards offset by a valuation allowance of $ 2.2 million and $ 1.7 million, respectively. The majority of the tax loss carryforwards are in jurisdictions that allow a twenty-year carry-forward period. These losses do not begin to expire until the 2038 tax year, and the Company anticipates utilizing $ 3.7 million of the net operating loss carryforwards as of December 31, 2024. </context>
|
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
|
As of December 31, 2024 and 2023, we had $ 5.9 million and $ 4.7 million of net operating loss carryforwards offset by a valuation allowance of $ 2.2 million and $ 1.7 million, respectively. The majority of the tax loss carryforwards are in jurisdictions that allow a twenty-year carry-forward period. These losses do not begin to expire until the 2038 tax year, and the Company anticipates utilizing $ 3.7 million of the net operating loss carryforwards as of December 31, 2024.
|
text
|
4.7
|
monetaryItemType
|
text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, we had $ 5.9 million and $ 4.7 million of net operating loss carryforwards offset by a valuation allowance of $ 2.2 million and $ 1.7 million, respectively. The majority of the tax loss carryforwards are in jurisdictions that allow a twenty-year carry-forward period. These losses do not begin to expire until the 2038 tax year, and the Company anticipates utilizing $ 3.7 million of the net operating loss carryforwards as of December 31, 2024. </context>
|
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
|
As of December 31, 2024 and 2023, we had $ 5.9 million and $ 4.7 million of net operating loss carryforwards offset by a valuation allowance of $ 2.2 million and $ 1.7 million, respectively. The majority of the tax loss carryforwards are in jurisdictions that allow a twenty-year carry-forward period. These losses do not begin to expire until the 2038 tax year, and the Company anticipates utilizing $ 3.7 million of the net operating loss carryforwards as of December 31, 2024.
|
text
|
3.7
|
monetaryItemType
|
text: <entity> 3.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, we had $ 5.9 million and $ 4.7 million of net operating loss carryforwards offset by a valuation allowance of $ 2.2 million and $ 1.7 million, respectively. The majority of the tax loss carryforwards are in jurisdictions that allow a twenty-year carry-forward period. These losses do not begin to expire until the 2038 tax year, and the Company anticipates utilizing $ 3.7 million of the net operating loss carryforwards as of December 31, 2024. </context>
|
us-gaap:OperatingLossCarryforwards
|
We manage our business under two reportable segments, consisting of the acquisition and management of stream interests and the acquisition and management of royalty interests. Our President and Chief Executive Officer serves as our Chief Operating Decision Maker ("CODM") and is responsible for reviewing segment performance and making decisions regarding resource allocation. In addition to revenue, our CODM regularly reviews cost of sales, production taxes and depletion for each of our reportable segments. Royal Gold’s long-lived assets (stream and royalty interests, net) as of December 31, 2024 and 2023 are geographically distributed as shown in the following table (amounts in thousands):
|
text
|
two
|
integerItemType
|
text: <entity> two </entity> <entity type> integerItemType </entity type> <context> We manage our business under two reportable segments, consisting of the acquisition and management of stream interests and the acquisition and management of royalty interests. Our President and Chief Executive Officer serves as our Chief Operating Decision Maker ("CODM") and is responsible for reviewing segment performance and making decisions regarding resource allocation. In addition to revenue, our CODM regularly reviews cost of sales, production taxes and depletion for each of our reportable segments. Royal Gold’s long-lived assets (stream and royalty interests, net) as of December 31, 2024 and 2023 are geographically distributed as shown in the following table (amounts in thousands): </context>
|
us-gaap:NumberOfReportableSegments
|
As of December 31, 2024, our conditional funding schedule of $ 163.75 million, as part of the Ilovica gold stream acquisition entered into in October 2014, remains subject to certain conditions.
|
text
|
163.75
|
monetaryItemType
|
text: <entity> 163.75 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, our conditional funding schedule of $ 163.75 million, as part of the Ilovica gold stream acquisition entered into in October 2014, remains subject to certain conditions. </context>
|
us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
|
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock.
|
text
|
18576527
|
sharesItemType
|
text: <entity> 18576527 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context>
|
us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
|
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock.
|
text
|
3300000
|
sharesItemType
|
text: <entity> 3300000 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context>
|
us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
|
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock.
|
text
|
6723473
|
sharesItemType
|
text: <entity> 6723473 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context>
|
us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
|
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock.
|
text
|
34.00
|
perShareItemType
|
text: <entity> 34.00 </entity> <entity type> perShareItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context>
|
us-gaap:SaleOfStockPricePerShare
|
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock.
|
text
|
600.0
|
monetaryItemType
|
text: <entity> 600.0 </entity> <entity type> monetaryItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context>
|
us-gaap:ProceedsFromIssuanceInitialPublicOffering
|
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock.
|
text
|
67917432
|
sharesItemType
|
text: <entity> 67917432 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context>
|
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock.
|
text
|
5104017
|
sharesItemType
|
text: <entity> 5104017 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context>
|
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million.
|
text
|
534.7
|
monetaryItemType
|
text: <entity> 534.7 </entity> <entity type> monetaryItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context>
|
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
|
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million.
|
text
|
4861113
|
sharesItemType
|
text: <entity> 4861113 </entity> <entity type> sharesItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context>
|
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
|
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million.
|
text
|
10502390
|
sharesItemType
|
text: <entity> 10502390 </entity> <entity type> sharesItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context>
|
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million.
|
text
|
723341
|
sharesItemType
|
text: <entity> 723341 </entity> <entity type> sharesItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context>
|
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
|
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million.
|
text
|
1347456
|
sharesItemType
|
text: <entity> 1347456 </entity> <entity type> sharesItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context>
|
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million.
|
text
|
34.00
|
perShareItemType
|
text: <entity> 34.00 </entity> <entity type> perShareItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context>
|
us-gaap:SaleOfStockPricePerShare
|
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million.
|
text
|
189.9
|
monetaryItemType
|
text: <entity> 189.9 </entity> <entity type> monetaryItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context>
|
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock.
|
text
|
2000000000
|
sharesItemType
|
text: <entity> 2000000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. </context>
|
us-gaap:CommonStockSharesAuthorized
|
In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock.
|
text
|
140000000
|
sharesItemType
|
text: <entity> 140000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. </context>
|
us-gaap:CommonStockSharesAuthorized
|
In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock.
|
text
|
100000000
|
sharesItemType
|
text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. </context>
|
us-gaap:CommonStockSharesAuthorized
|
In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock.
|
text
|
100000000
|
sharesItemType
|
text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. </context>
|
us-gaap:PreferredStockSharesAuthorized
|
Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively.
|
text
|
9.2
|
monetaryItemType
|
text: <entity> 9.2 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. </context>
|
us-gaap:AdvertisingExpense
|
Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively.
|
text
|
8.2
|
monetaryItemType
|
text: <entity> 8.2 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. </context>
|
us-gaap:AdvertisingExpense
|
Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively.
|
text
|
34.4
|
monetaryItemType
|
text: <entity> 34.4 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. </context>
|
us-gaap:AdvertisingExpense
|
Prior to our IPO, deferred offering costs, which consisted of direct incremental legal, accounting, consulting, and other fees related to the IPO, were capitalized in other noncurrent assets on the consolidated balance sheets. After the IPO, the deferred offering costs were reclassified into additional paid-in capital as an offset against IPO proceeds. Deferred offering costs included in other noncurrent assets were $ 16.5 million as of December 31, 2023.
|
text
|
16.5
|
monetaryItemType
|
text: <entity> 16.5 </entity> <entity type> monetaryItemType </entity type> <context> Prior to our IPO, deferred offering costs, which consisted of direct incremental legal, accounting, consulting, and other fees related to the IPO, were capitalized in other noncurrent assets on the consolidated balance sheets. After the IPO, the deferred offering costs were reclassified into additional paid-in capital as an offset against IPO proceeds. Deferred offering costs included in other noncurrent assets were $ 16.5 million as of December 31, 2023. </context>
|
us-gaap:DeferredCostsCurrentAndNoncurrent
|
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively.
|
text
|
14.9
|
monetaryItemType
|
text: <entity> 14.9 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context>
|
us-gaap:ContractWithCustomerLiability
|
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively.
|
text
|
7.4
|
monetaryItemType
|
text: <entity> 7.4 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context>
|
us-gaap:ContractWithCustomerLiability
|
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively.
|
text
|
7.2
|
monetaryItemType
|
text: <entity> 7.2 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context>
|
us-gaap:ContractWithCustomerLiabilityRevenueRecognized
|
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively.
|
text
|
7.8
|
monetaryItemType
|
text: <entity> 7.8 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context>
|
us-gaap:ContractWithCustomerLiabilityRevenueRecognized
|
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively.
|
text
|
6.5
|
monetaryItemType
|
text: <entity> 6.5 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context>
|
us-gaap:ContractWithCustomerLiabilityRevenueRecognized
|
As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027.
|
text
|
252.9
|
monetaryItemType
|
text: <entity> 252.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. </context>
|
us-gaap:RevenueRemainingPerformanceObligation
|
As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027.
|
text
|
114.6
|
monetaryItemType
|
text: <entity> 114.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. </context>
|
us-gaap:RevenueRemainingPerformanceObligation
|
As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027.
|
text
|
113.2
|
monetaryItemType
|
text: <entity> 113.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. </context>
|
us-gaap:RevenueRemainingPerformanceObligation
|
As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027.
|
text
|
25.1
|
monetaryItemType
|
text: <entity> 25.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. </context>
|
us-gaap:RevenueRemainingPerformanceObligation
|
We compute net income (loss) per share of Class A and Class B common stock using the two-class method required for multiple classes of common stock and participating securities. Prior to the IPO, our participating securities included Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock, as the holders of these series of preferred stock were entitled to receive noncumulative dividends subject to certain requirements at an annual rate of 8 % of the respective original issue price then in effect in the event that a dividend was paid on common stock.
|
text
|
8
|
percentItemType
|
text: <entity> 8 </entity> <entity type> percentItemType </entity type> <context> We compute net income (loss) per share of Class A and Class B common stock using the two-class method required for multiple classes of common stock and participating securities. Prior to the IPO, our participating securities included Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock, as the holders of these series of preferred stock were entitled to receive noncumulative dividends subject to certain requirements at an annual rate of 8 % of the respective original issue price then in effect in the event that a dividend was paid on common stock. </context>
|
us-gaap:PreferredStockDividendRatePercentage
|
In connection with our IPO, our Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, and Series F preferred stock converted on a one -to-one basis into 67,917,432 shares of Class B common stock, and our Series F-1 preferred stock converted on a one -to-one basis into 5,104,017 shares of Class A common stock. These shares are weighted in the denominator of net income (loss) per share for Class A and Class B common stock for the portion of the time outstanding subsequent to our IPO.
|
text
|
67917432
|
sharesItemType
|
text: <entity> 67917432 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, our Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, and Series F preferred stock converted on a one -to-one basis into 67,917,432 shares of Class B common stock, and our Series F-1 preferred stock converted on a one -to-one basis into 5,104,017 shares of Class A common stock. These shares are weighted in the denominator of net income (loss) per share for Class A and Class B common stock for the portion of the time outstanding subsequent to our IPO. </context>
|
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
In connection with our IPO, our Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, and Series F preferred stock converted on a one -to-one basis into 67,917,432 shares of Class B common stock, and our Series F-1 preferred stock converted on a one -to-one basis into 5,104,017 shares of Class A common stock. These shares are weighted in the denominator of net income (loss) per share for Class A and Class B common stock for the portion of the time outstanding subsequent to our IPO.
|
text
|
5104017
|
sharesItemType
|
text: <entity> 5104017 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, our Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, and Series F preferred stock converted on a one -to-one basis into 67,917,432 shares of Class B common stock, and our Series F-1 preferred stock converted on a one -to-one basis into 5,104,017 shares of Class A common stock. These shares are weighted in the denominator of net income (loss) per share for Class A and Class B common stock for the portion of the time outstanding subsequent to our IPO. </context>
|
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
As of December 31, 2024, the amortized cost of marketable securities with maturities less than one year was $ 989.2 million. The amortized cost of marketable securities with maturities between one and five years was $ 288.4 million.
|
text
|
989.2
|
monetaryItemType
|
text: <entity> 989.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the amortized cost of marketable securities with maturities less than one year was $ 989.2 million. The amortized cost of marketable securities with maturities between one and five years was $ 288.4 million. </context>
|
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
As of December 31, 2024, the amortized cost of marketable securities with maturities less than one year was $ 989.2 million. The amortized cost of marketable securities with maturities between one and five years was $ 288.4 million.
|
text
|
288.4
|
monetaryItemType
|
text: <entity> 288.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the amortized cost of marketable securities with maturities less than one year was $ 989.2 million. The amortized cost of marketable securities with maturities between one and five years was $ 288.4 million. </context>
|
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively.
|
text
|
4.7
|
monetaryItemType
|
text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context>
|
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively.
|
text
|
12.0
|
monetaryItemType
|
text: <entity> 12.0 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context>
|
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively.
|
text
|
16.4
|
monetaryItemType
|
text: <entity> 16.4 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context>
|
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively.
|
text
|
5.3
|
monetaryItemType
|
text: <entity> 5.3 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context>
|
us-gaap:OperatingLeasePayments
|
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively.
|
text
|
8.9
|
monetaryItemType
|
text: <entity> 8.9 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context>
|
us-gaap:OperatingLeasePayments
|
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively.
|
text
|
9.6
|
monetaryItemType
|
text: <entity> 9.6 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context>
|
us-gaap:OperatingLeasePayments
|
On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services.
|
text
|
19.9
|
monetaryItemType
|
text: <entity> 19.9 </entity> <entity type> monetaryItemType </entity type> <context> On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. </context>
|
us-gaap:BusinessCombinationConsiderationTransferred1
|
On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services.
|
text
|
17.1
|
monetaryItemType
|
text: <entity> 17.1 </entity> <entity type> monetaryItemType </entity type> <context> On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. </context>
|
us-gaap:PaymentsToAcquireBusinessesGross
|
On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services.
|
text
|
2.8
|
monetaryItemType
|
text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. </context>
|
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
|
Of the aggregate purchase consideration, $ 4.3 million was allocated to developed technology with a useful life of three years , $ 15.9 million was allocated to goodwill, and the remainder was allocated to other assets acquired and liabilities assumed.
|
text
|
4.3
|
monetaryItemType
|
text: <entity> 4.3 </entity> <entity type> monetaryItemType </entity type> <context> Of the aggregate purchase consideration, $ 4.3 million was allocated to developed technology with a useful life of three years , $ 15.9 million was allocated to goodwill, and the remainder was allocated to other assets acquired and liabilities assumed. </context>
|
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
|
Of the aggregate purchase consideration, $ 4.3 million was allocated to developed technology with a useful life of three years , $ 15.9 million was allocated to goodwill, and the remainder was allocated to other assets acquired and liabilities assumed.
|
text
|
15.9
|
monetaryItemType
|
text: <entity> 15.9 </entity> <entity type> monetaryItemType </entity type> <context> Of the aggregate purchase consideration, $ 4.3 million was allocated to developed technology with a useful life of three years , $ 15.9 million was allocated to goodwill, and the remainder was allocated to other assets acquired and liabilities assumed. </context>
|
us-gaap:Goodwill
|
Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022.
|
text
|
9.2
|
monetaryItemType
|
text: <entity> 9.2 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. </context>
|
us-gaap:AmortizationOfIntangibleAssets
|
Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022.
|
text
|
9.0
|
monetaryItemType
|
text: <entity> 9.0 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. </context>
|
us-gaap:AmortizationOfIntangibleAssets
|
Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022.
|
text
|
immaterial
|
monetaryItemType
|
text: <entity> immaterial </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. </context>
|
us-gaap:AmortizationOfIntangibleAssets
|
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024.
|
text
|
750.0
|
monetaryItemType
|
text: <entity> 750.0 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context>
|
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
|
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024.
|
text
|
100.0
|
monetaryItemType
|
text: <entity> 100.0 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context>
|
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
|
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024.
|
text
|
4.9
|
monetaryItemType
|
text: <entity> 4.9 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context>
|
us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
|
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024.
|
text
|
95.1
|
monetaryItemType
|
text: <entity> 95.1 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context>
|
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
|
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024.
|
text
|
745.1
|
monetaryItemType
|
text: <entity> 745.1 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context>
|
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
|
On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility.
|
text
|
0.5
|
percentItemType
|
text: <entity> 0.5 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. </context>
|
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
|
On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility.
|
text
|
1.0
|
percentItemType
|
text: <entity> 1.0 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. </context>
|
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
|
On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility.
|
text
|
1.25
|
percentItemType
|
text: <entity> 1.25 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. </context>
|
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
|
On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility.
|
text
|
0.15
|
percentItemType
|
text: <entity> 0.15 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. </context>
|
us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
|
We enter into contracts with non-cancellable purchase obligations, primarily related to third-party cloud infrastructure agreements under which we are granted access to certain cloud services. During the year ended December 31, 2024, we signed addenda to our cloud services agreements. We are committed under these arrangements to spend at least $ 480.0 million through September 2026, before consideration of any credits that may be earned during the term. We have met all minimum purchase commitments under these agreements during the periods presented.
|
text
|
480.0
|
monetaryItemType
|
text: <entity> 480.0 </entity> <entity type> monetaryItemType </entity type> <context> We enter into contracts with non-cancellable purchase obligations, primarily related to third-party cloud infrastructure agreements under which we are granted access to certain cloud services. During the year ended December 31, 2024, we signed addenda to our cloud services agreements. We are committed under these arrangements to spend at least $ 480.0 million through September 2026, before consideration of any credits that may be earned during the term. We have met all minimum purchase commitments under these agreements during the periods presented. </context>
|
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
|
Immediately prior to the completion of our IPO, all of our then-outstanding shares of convertible preferred stock were automatically converted into 5,104,017 and 67,917,432 shares of our Class A and Class B common stock, respectively.
|
text
|
5104017
|
sharesItemType
|
text: <entity> 5104017 </entity> <entity type> sharesItemType </entity type> <context> Immediately prior to the completion of our IPO, all of our then-outstanding shares of convertible preferred stock were automatically converted into 5,104,017 and 67,917,432 shares of our Class A and Class B common stock, respectively. </context>
|
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.